Visual Perception in Schizophrenia
Part of paid clinical trials in Rochester, New York.
- Sponsor
- University of Rochester
- Study ID
- NCT06911931
- Status
- Recruiting
Conditions
- Bipolar Disorder
- Schizo Affective Disorder
- Schizophrenia Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- EEG measure of visual processing — OTHERNon-invasive scalp EEG measure of early cortical visual processing.
Study Details
This study aims to identify novel markers of psychosis using electroencephalography (EEG).
Key Dates
- Start date
- Nov 3, 2025
- Status verified
- Nov 2025
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 84 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: All participants
Primary Outcome Measure
mean amplitude of EEG visual response [ Time Frame: Day 1 ]
Central Contacts
- Edmund Lalor, PhD585-275-3077
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Rochester | Rochester | New York | 14642 |
Find similar trials in Rochester, NY
By condition
By specialty
By research site
Related Studies
- Personalized Mobile Cognitive Behavioral Therapy ApplicationRecruiting · Weill Medical College of Cornell University · New York, New York
- iTBS to Enhance Social Cognition in People With PsychosisRecruiting · Northwell Health · Glen Oaks, New York
- Use of Ketosis in Modulating Metabolic Pathways in Bipolar DisorderRecruiting · Stony Brook University · Belmont, Massachusetts
- A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or LamotriginePHASE3 · Recruiting · Bristol-Myers Squibb · Bentonville, Arkansas